tiprankstipranks
Poseida Therapeutics nominates new CAR-T candidate under Roche collaboration
PremiumThe FlyPoseida Therapeutics nominates new CAR-T candidate under Roche collaboration
1M ago
Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1
Premium
The Fly
Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1
2M ago
Poseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1
Premium
The Fly
Poseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1
2M ago
Poseida Therapeutics reports Q1 EPS (25c), consensus (42c).
PremiumThe FlyPoseida Therapeutics reports Q1 EPS (25c), consensus (42c).
6M ago
Poseida Therapeutics highlights new data on lead genetic medicines programs
Premium
The Fly
Poseida Therapeutics highlights new data on lead genetic medicines programs
7M ago
William Blair views Poseida’s added collaboration with Astellas ‘favorably’
Premium
The Fly
William Blair views Poseida’s added collaboration with Astellas ‘favorably’
7M ago
Poseida Therapeutics management to meet with Piper Sandler
PremiumThe FlyPoseida Therapeutics management to meet with Piper Sandler
7M ago
Poseida Therapeutics files to sell 8.33M shares of common stock for holders
Premium
The Fly
Poseida Therapeutics files to sell 8.33M shares of common stock for holders
8M ago
Poseida Therapeutics Unveils Cancer Research Breakthroughs at AACR
Premium
Company Announcements
Poseida Therapeutics Unveils Cancer Research Breakthroughs at AACR
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100